These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22748003)

  • 1. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
    Unemo M; Golparian D; Potočnik M; Jeverica S
    Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
    Unemo M; Golparian D; Hestner A
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
    Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
    Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
    Hustig A; Bell C; Waddell R
    Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
    van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
    Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.
    Unemo M; Golparian D; Syversen G; Vestrheim DF; Moi H
    Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
    Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
    J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.
    Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D
    J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
    Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
    Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea.
    Rodgers S; Murgatroyd M; Perez K; Kingston M; Lee V
    Int J STD AIDS; 2014 Feb; 25(2):145-7. PubMed ID: 23970641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK national guideline for the management of gonorrhoea in adults, 2011.
    Bignell C; Fitzgerald M; ;
    Int J STD AIDS; 2011 Oct; 22(10):541-7. PubMed ID: 21998172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated pharyngeal Neisseria gonorrhoeae in heterosexual male contacts.
    Thomson-Glover R; Brown R; Edirisinghe DN
    Int J STD AIDS; 2013 Dec; 24(12):983-5. PubMed ID: 23970625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant
    Poncin T; Fouere S; Braille A; Camelena F; Agsous M; Bebear C; Kumanski S; Lot F; Mercier-Delarue S; Ngangro NN; Salmona M; Schnepf N; Timsit J; Unemo M; Bercot B
    Euro Surveill; 2018 May; 23(21):. PubMed ID: 29845928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia.
    Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM
    Sex Health; 2013 Nov; 10(5):460-2. PubMed ID: 24028864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.
    Unemo M; Golparian D; Stary A; Eigentler A
    Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant
    Golparian D; Rose L; Lynam A; Mohamed A; Bercot B; Ohnishi M; Crowley B; Unemo M
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.